UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Antipsychotic medications for cocaine dependence

Cochrane database of systematic reviews, 2007-07 (3), p.CD006306

2007

Volltextzugriff (PDF)

Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs

Journal of controlled release, 2018-07, Vol.281, p.139-177

2018

Volltextzugriff (PDF)

Risperidone for autism spectrum disorder

Cochrane database of systematic reviews, 2007-01, Vol.2010 (1), p.CD005040

2007

Volltextzugriff (PDF)

Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials

Molecular psychiatry, 2022-02, Vol.27 (2), p.1136-1144

2022

Volltextzugriff (PDF)

Risperidone: a review of its use in the treatment of irritability associated with autistic disorder in children and adolescents

Paediatric drugs, 2007, Vol.9 (5), p.343-354

2007

Volltextzugriff (PDF)

Long-Acting Injectable Risperidone for Relapse Prevention and Control of Breakthrough Symptoms After a Recent First Episode of Schizophrenia. A Randomized Clinical Trial

JAMA psychiatry (Chicago, Ill.), 2015-08, Vol.72 (8), p.822

2015

Volltextzugriff (PDF)

A 24-week, multicenter, open-label, randomized study to compare changes in glucose metabolism in patients with schizophrenia receiving treatment with olanzapine, quetiapine, or risperidone

The journal of clinical psychiatry, 2009-04, Vol.70 (4), p.487-499

2009

Volltextzugriff (PDF)

Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis

JAMA psychiatry (Chicago, Ill.), 2016-03, Vol.73 (3), p.199

2016

Volltextzugriff (PDF)

Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents

JAMA : the journal of the American Medical Association, 2009-10, Vol.302 (16), p.1765

2009

Volltextzugriff (PDF)

Differentiating the effect of antipsychotic medication and illness on brain volume reductions in first-episode psychosis: A Longitudinal, Randomised, Triple-blind, Placebo-controlled MRI Study

Neuropsychopharmacology (New York, N.Y.), 2021-07, Vol.46 (8), p.1494-1501

2021

Volltextzugriff (PDF)

The efficacy of cariprazine in negative symptoms of schizophrenia: Post hoc analyses of PANSS individual items and PANSS-derived factors

European psychiatry, 2019-05, Vol.58, p.1-9

2019

Volltextzugriff (PDF)

Meta-analysis of the efficacy of treatments for posttraumatic stress disorder

The journal of clinical psychiatry, 2013-06, Vol.74 (6), p.e541-e550

2013

Volltextzugriff (PDF)

Neuropharmacological effect of risperidone: From chemistry to medicine

Chemico-biological interactions, 2023-01, Vol.369, p.110296-110296, Article 110296

2023

Volltextzugriff (PDF)

Real-world Effectiveness of Pharmacologic Treatments for the Prevention of Rehospitalization in a Finnish Nationwide Cohort of Patients With Bipolar Disorder

JAMA psychiatry (Chicago, Ill.), 2018-04, Vol.75 (4), p.347

2018

Volltextzugriff (PDF)

Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations

JAMA psychiatry (Chicago, Ill.), 2016-09, Vol.73 (9), p.938

2016

Volltextzugriff (PDF)

Antipsychotics for treatment of delirium in hospitalised non-ICU patients

Cochrane database of systematic reviews, 2018-06, Vol.6 (6), p.CD005594

2018

Volltextzugriff (PDF)

A systematic review and combined analysis of therapeutic drug monitoring studies for long-acting risperidone

Expert review of clinical pharmacology, 2017-09, Vol.10 (9), p.965-981

2017

Volltextzugriff (PDF)

Second-generation antipsychotics and metabolism alterations: a systematic review of the role of the gut microbiome

Psychopharmacology, 2019-05, Vol.236 (5), p.1491-1512

2019

Volltextzugriff (PDF)

Risk of Mortality Among Individual Antipsychotics in Patients With Dementia

The American journal of psychiatry, 2012-01, Vol.169 (1), p.71-79

2012

Volltextzugriff (PDF)

Women with Schizophrenia-Spectrum Disorders After Menopause: A Vulnerable Group for Relapse

Schizophrenia bulletin, 2023-01, Vol.49 (1), p.136-143

2023

Volltextzugriff (PDF)

Atypical antipsychotics for disruptive behaviour disorders in children and youths

Cochrane database of systematic reviews, 2017-08, Vol.8 (8), p.CD008559

2017

Volltextzugriff (PDF)

Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia

The New England journal of medicine, 2005-09, Vol.353 (12), p.1209-1223

2005

Volltextzugriff (PDF)

Changes in metabolism and microbiota after 24-week risperidone treatment in drug naïve, normal weight patients with first episode schizophrenia

Schizophrenia research, 2018-11, Vol.201, p.299-306

2018

Volltextzugriff (PDF)

Anti-inflammatory effects of 2nd generation antipsychotics in patients with schizophrenia: A systematic review and meta-analysis

Journal of psychiatric research, 2023-04, Vol.160, p.126-136

2023

Volltextzugriff (PDF)

Current Pharmacological Approaches to Reduce Chorea in Huntington’s Disease

Drugs (New York, N.Y.), 2017-01, Vol.77 (1), p.29-46

2017

Volltextzugriff (PDF)

1 – 25 von 4.493

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(4.212)
Mit Volltextzugriff
(3.004)

Publikationsform

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(4.397)
Risperidone - Therapeutic Use
(3.829)
Antipsychotic Agents - Therapeutic Use
(3.781)
Science & Technology
(3.764)
Life Sciences & Biomedicine
(3.738)
Psychiatry
(2.794)
Male
(2.759)
Female
(2.572)
Schizophrenia - Drug Therapy
(2.176)
Adult
(2.123)
Risperidone
(1.612)
Antipsychotic Agents - Adverse Effects
(1.590)
Biological And Medical Sciences
(1.565)
Medical Sciences
(1.558)
Risperidone - Adverse Effects
(1.462)
Schizophrenia
(1.377)
Middle Aged
(1.325)
Pharmacology. Drug Treatments
(1.321)
Pharmacology & Pharmacy
(1.304)
Psychology. Psychoanalysis. Psychiatry
(1.285)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Antipsychotic medications for cocaine dependence

Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs

Risperidone for autism spectrum disorder

Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials

Risperidone: a review of its use in the treatment of irritability associated with autistic disorder in children and adolescents

Long-Acting Injectable Risperidone for Relapse Prevention and Control of Breakthrough Symptoms After a Recent First Episode of Schizophrenia. A Randomized Clinical Trial

A 24-week, multicenter, open-label, randomized study to compare changes in glucose metabolism in patients with schizophrenia receiving treatment with olanzapine, quetiapine, or risperidone

Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis

Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents

Differentiating the effect of antipsychotic medication and illness on brain volume reductions in first-episode psychosis: A Longitudinal, Randomised, Triple-blind, Placebo-controlled MRI Study

The efficacy of cariprazine in negative symptoms of schizophrenia: Post hoc analyses of PANSS individual items and PANSS-derived factors

Meta-analysis of the efficacy of treatments for posttraumatic stress disorder

Neuropharmacological effect of risperidone: From chemistry to medicine

Real-world Effectiveness of Pharmacologic Treatments for the Prevention of Rehospitalization in a Finnish Nationwide Cohort of Patients With Bipolar Disorder

Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations

Antipsychotics for treatment of delirium in hospitalised non-ICU patients

A systematic review and combined analysis of therapeutic drug monitoring studies for long-acting risperidone

Second-generation antipsychotics and metabolism alterations: a systematic review of the role of the gut microbiome

Risk of Mortality Among Individual Antipsychotics in Patients With Dementia

Women with Schizophrenia-Spectrum Disorders After Menopause: A Vulnerable Group for Relapse

Atypical antipsychotics for disruptive behaviour disorders in children and youths

Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia

Changes in metabolism and microbiota after 24-week risperidone treatment in drug naïve, normal weight patients with first episode schizophrenia

Anti-inflammatory effects of 2nd generation antipsychotics in patients with schizophrenia: A systematic review and meta-analysis

Current Pharmacological Approaches to Reduce Chorea in Huntington’s Disease

Suchergebnisse filtern